Skip to main content

Table 1 Baseline characteristics of enrolled patients

From: Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: a cross-sectional study

Group Control (n = 35) HIV (n = 34)
Gender (male: female) 29: 6 29: 5
Age (year) 44.69 ± 8.88 45.18 ± 7.73
Dialysis vintage (month) 25 (17–37) 26 (13–36)
spKt/V 1.34 ± 0.23 1.27 ± 0.16
Serum albumin (g/L) 42.10 (40.35–43.40) 41.95 (38.88–43.55)
Hospitalizations (times/6 m) 0 (0–0) 0 (0–1)
Infections (times/6 m) 0 (0–0) 0 (0–0)
Medications
Antihypertensive drugs (Y/N) 33/2 31/3
Phosphate binders (Y/N) 34/1 31/3
Active vitamin D or Cinacalcet (Y/N) 33/2 34/0
α-Ketoacid (Y/N) 13/22 2/32*
  1. Dialysis vintage, serum albumin, hospitalizations and infections expressed as median IQR, Age and spKt/V expressed as means ±SEM. Results of HIV group are not statistically different from control group except the proportion of treatment with α-ketoacid.
  2. *p < 0.05 compared to control.